One study proposed that the bypass pathways (defined as collateral dependencies (CDs)) that maintain cancer cell survival may be different from those dependent on the excessive activation of KRAS signalling when acute deprivation drives oncogene activity with KRAS (G12C) inhibitors and target CDs will promote the response to KRASG12C inhibitors191. This evidence concerns the gene KRAS and cancer.